Zonghua Qin

Title: Zonghua Qin: Innovator in Antimicrobials and Anticoccidial Drugs

Introduction:

Zonghua Qin is a prolific inventor and researcher hailing from Guangzhou, China. With a passion for developing innovative solutions in the field of pharmaceuticals, Qin has made significant contributions to the areas of antimicrobials and anticoccidial drugs. With six patents to his name, Qin's work has garnered attention for its potential to combat gram-negative bacterial infections and improve livestock animal health.

Latest Patents:

Qin's latest patents showcase his expertise in developing novel solutions for challenging medical and agricultural problems. One of his notable patents is titled "Use of substituted benzylideneguanidine derivatives as synergists for polymyxin antibiotics." This patent details the use of a substituted benzoguanidine derivative as a polymyxin antibiotic synergist for inhibiting sensitive strains and reversing drug resistance. The patent highlights its application for the treatment of gram-negative bacterial infections in humans and animals.

Another groundbreaking patent by Qin is titled "Derivatives of 1H-imidazole-4,5-dicarboxamide and use thereof in preparation of anticoccidial drugs." This patent reveals Qin's innovative approach to developing derivatives of 1H-imidazole-4,5-dicarboxamide as effective anticoccidial drugs. These derivatives exhibit significant efficacy against coccidia strains resistant to other anticoccidial drugs.

Career Highlights:

Throughout his career, Qin has held key positions in renowned companies within the biotechnology and feed-additive sectors. One such company is Guangzhou Insighter Biotechnology Co., Ltd., where Qin's expertise in drug development and innovative research methods has played a vital role in driving the company's success.

Qin's career achievements also include his contributions to Guangzhou Origmol Feed-additive Co., Ltd. His work in developing growth-promoting feed additives has significantly contributed to the improvement of livestock health and productivity.

Collaborations:

In the pursuit of innovation, Qin has collaborated with esteemed colleagues in the field. Notable among his coworkers are Xianfeng Peng and Fang Li. These collaborative efforts have undoubtedly led to groundbreaking advancements in the pharmaceutical domain, and their collective contributions have brought recognition to their research and patent applications.

Conclusion:

Zonghua Qin's relentless dedication to innovation has paved the way for groundbreaking advancements in the fields of antimicrobials and anticoccidial drugs. Through his patents, Qin has demonstrated his ability to develop novel solutions that address crucial medical and agricultural challenges. As a valued contributor to Guangzhou Insighter Biotechnology Co., Ltd., and Guangzhou Origmol Feed-additive Co., Ltd., Qin's work continues to shape the future of pharmaceutical research and development.